Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $12.0300 (-3.45%) ($11.9500 - $12.4500) on Wed. Aug. 7, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.96% (three month average) | RSI | 19 | Latest Price | $12.0300(-3.45%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -3.4% a day on average for past five trading days. | Weekly Trend | ATRA declines -8.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -1.98% in a week (0% probabilities). VXX(-35%) VIXM(-35%) TLT(-13%) UNG(-7%) IFRA(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.98% (StdDev 3.96%) | Hourly BBV | 0 () | Intraday Trend | -1.6% | | | |
|
1 - 5 Day Possible Target | $-9.77(-181.21%) | Resistance Level | $14.75 | 5 Day Moving Average | $12.69(-5.2%) | 10 Day Moving Average | $13.54(-11.15%) | 20 Day Moving Average | $14.75(-18.44%) | To recent high | -64.9% | To recent low | 0% | Market Cap | $894m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |